Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy
The Journal of Allergy and Clinical Immunology, 06/08/2012
Swamy RS et al. – The results of this pilot study suggest that dual sublingual immunotherapy (SLIT) could be an effective means to treat subjects with sensitivities to a variety of allergens and that long–term tolerance might be induced by epigenetic modifications of Foxp3 in memory regulatory T cells.
